Håkan Mellstedt
- Immunology top 0.2%
- Oncology top 0.5%
- Genetics top 0.1%
- Molecular Biology top 2%
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Anders ÖsterborgMagnus BjörkholmG. HolmMahmood Jeddi‐TehraniEva KimbyGöran HolmJeanette LundinMikael Jondal
- Topics
- Chronic Lymphocytic Leukemia Research (123 papers)Lymphoma Diagnosis and Treatment (70 papers)Immunotherapy and Immune Responses (70 papers)
- Cited by
- GeneticsImmunologyHematology
In The Last Decade
Håkan Mellstedt
296 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 5.4k
- Oncology 3.5k
- Genetics 2.8k
- Molecular Biology 2.7k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Håkan Mellstedt
This map shows the geographic impact of Håkan Mellstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkan Mellstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkan Mellstedt more than expected).
Fields of papers citing papers by Håkan Mellstedt
This network shows the impact of papers produced by Håkan Mellstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkan Mellstedt. The network helps show where Håkan Mellstedt may publish in the future.
Co-authorship network of co-authors of Håkan Mellstedt
This figure shows the co-authorship network connecting the top 25 collaborators of Håkan Mellstedt. A scholar is included among the top collaborators of Håkan Mellstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Håkan Mellstedt. Håkan Mellstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 59 | |
| 6 | 16 | |
| 7 | 63 | |
| 8 | 145 | |
| 9 | 3 | |
| 10 | 44 | |
| 11 | 203 | |
| 12 | 43 | |
| 13 | 45 | |
| 14 | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). | 4 |
| 15 | 6 | |
| 16 | Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro. | 19 |
| 17 | 37 | |
| 18 | Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression. | 29 |
| 19 | 10 | |
| 20 | 22 |
About Håkan Mellstedt
Håkan Mellstedt is a scholar working on Genetics, Immunology and Hematology, having authored 298 papers that have together received 9.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (123 papers), Lymphoma Diagnosis and Treatment (70 papers) and Immunotherapy and Immune Responses (70 papers). The work is most often cited by research in Genetics (2.8k citations), Immunology (5.4k citations) and Hematology (1.5k citations). Håkan Mellstedt has collaborated with scholars based in Sweden, Iran and France. Frequent co-authors include Anders Österborg, Magnus Björkholm, Anders Österborg, G. Holm, Mahmood Jeddi‐Tehrani, Eva Kimby, Göran Holm, Jeanette Lundin, Mikael Jondal and Jan‐Erik Frödin. Their work appears in journals such as Nature, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.